...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: RBC unregistered to registered account

Correction: Seeing that RPS for RVX would continue on to perpetuity, ZCC would not be liquidated, but continue issuing dividends. But is that even possible logistically speaking?

 

Koo

Share
New Message
Please login to post a reply